Nomura Holdings, Inc.
Nomura Holdings, Inc. (NMR) Financial Performance & Income Statement Overview
Review Nomura Holdings, Inc. (NMR) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Nomura Holdings, Inc. (NMR) Income Statement & Financial Overview
Analyze Nomura Holdings, Inc.’s NMR earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1079.35B | $458.34B | $1241.57B | $1217.88B |
| Cost of Revenue | $671.47B | $695.96B | $758.24B | $823.18B |
| Gross Profit | $407.88B | $443.20B | $438.002B | $394.70B |
| Gross Profit Ratio | $0.38 | $0.97 | $0.35 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $197.85B | $190.89B | $184.67B | $208.72B |
| Operating Expenses | $310.14B | $215.58B | $435.71B | $351.51B |
| Total Costs & Expenses | $981.61B | $1016.01B | $1060.94B | $1114.95B |
| Interest Income | $0.00 | $745.46B | $762.96B | $788.55B |
| Interest Expense | $0.00 | $695.96B | $758.24B | $763.44B |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $16.11B |
| EBITDA | $97.74B | $138.28B | $133.01B | $119.04B |
| EBITDA Ratio | $0.09 | $0.30 | $0.11 | $0.10 |
| Operating Income | $97.74B | $138.28B | $133.01B | $102.93B |
| Operating Income Ratio | $0.09 | $0.30 | $0.11 | $0.08 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | -$142.79B |
| Income Before Tax | $97.74B | $138.28B | $133.01B | $102.93B |
| Income Before Tax Ratio | $0.09 | $0.30 | $0.11 | $0.08 |
| Income Tax Expense | $23.77B | $34.14B | $35.30B | $31.50B |
| Net Income | $71.97B | $101.44B | $98.39B | $68.94B |
| Net Income Ratio | $0.07 | $0.22 | $0.08 | $0.06 |
| EPS | $24.35 | $34.32 | $33.30 | $23.33 |
| Diluted EPS | $24.35 | $33.08 | $32.26 | $22.36 |
| Weighted Avg Shares Outstanding | $2.96B | $2.96B | $2.95B | $2.95B |
| Weighted Avg Shares Outstanding (Diluted) | $2.96B | $3.07B | $3.05B | $3.08B |
Over the past four quarters, Nomura Holdings, Inc. demonstrated steady revenue growth, increasing from $1217.88B in Q1 2024 to $1079.35B in Q4 2024. Operating income reached $97.74B in Q4 2024, maintaining a consistent 9% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $97.74B, reflecting operational efficiency. Net income dropped to $71.97B, with EPS at $24.35. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan